HeartLungAI Press Releases

Published on October 21, 2025 - 23:47 GMT

HeartLung Technologies Sets New Milestone with Nine Accepted Abstracts at AHA 2025 Showcasing the Power of AI-CVD™

NEW ORLEANS , LA, UNITED STATES, October 21, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies today announced a record-setting presence at the upcoming American Heart Association (AHA) Scientific Sessions 2025, with nine peer-reviewed studies accepted …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 17, 2025 - 14:48 GMT

American Heart Association Cites HeartLung’s AI-CAC™ and AI-CVD™ in Landmark Statement on Opportunistic Screening

HOUSTON, TX, UNITED STATES, October 17, 2025 /⁨EINPresswire.com⁩/ -- The American Heart Association (AHA) has released an official Scientific Statement in Circulation recognizing AI-enabled opportunistic detection of coronary artery calcium (CAC) on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 10, 2025 - 19:11 GMT

AI-CVD Myosteatosis and Hepatosteatosis Findings Linked to Diabetes and Heart Failure Presented at Mount Sinai I-ELCAP

NEW YORK CITY, NY, UNITED STATES, October 10, 2025 /⁨EINPresswire.com⁩/ -- Investigators from the AI-CVD™ consortium presented new results showing strong links between myosteatosis (fat infiltration in skeletal muscle) and hepatosteatosis (liver fat) with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 2, 2025 - 20:08 GMT

AI-CVD Investigators to Present at I-ELCAP’s 48th International Conference on Screening for Lung Cancer, Oct 9–11 in NYC

AI-CVD at I-ELCAP highlights a single low-dose CT that bridges lung cancer screening and cardiovascular prevention—register for in person or virtual attendance. NEW YORK CITY, NY, UNITED STATES, October 2, 2025 /⁨EINPresswire.com⁩/ -- AI-CVD investigators …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 27, 2025 - 17:51 GMT

HeartLung.AI to Present Seven Pioneering AI-CVD™ and AI-CAC ™ Studies at European Society of Cardiology 2025 in Madrid

HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensitive heart disease risk. HOUSTON, TX, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is proud to announce that …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 12, 2025 - 16:27 GMT

HeartLung’s Leadership Featured on Cardiac Wire Show to Discuss New AI for Early Cardiac Chamber Enlargement Detection

FDA Breakthrough-designated AutoChamber™ AI uses routine CT scans to detect early cardiac chamber enlargement and prevent serious heart disease. HOUSTON, TX, UNITED STATES, August 12, 2025 /⁨EINPresswire.com⁩/ -- In a compelling new interview featured on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 24, 2025 - 23:40 GMT

AI-Powered CT Chamber Volumetry Predicts Heart Failure Risk As Accurately As MRI, New Study Shows

AI-based LV volume from CAC scans predicts heart failure over 15 years as accurately as MRI, enabling early detection from routine CT imaging. HOUSTON, TX, UNITED STATES, July 24, 2025 /⁨EINPresswire.com⁩/ -- A new peer-reviewed study published in JCCT ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 24, 2025 - 23:36 GMT

AI Osteoporosis Screening: HeartLung and Imaging Wire on Saving Lives and Reducing Costs

HeartLung's medical leadership featured on Imaging Wire Show to discuss breakthrough new AI for opportunistic osteoporosis screening. HOUSTON, TX, UNITED STATES, July 24, 2025 /⁨EINPresswire.com⁩/ -- In an enlightening interview featured on The …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 8, 2025 - 19:26 GMT

HeartLung.AI Showcases Breakthrough AI-CVD™ and AI-CAC™ Technologies at SCCT 2025 in Montreal

HeartLung AI Showcases Breakthrough AI-CAC at SCCT 2025, Pushing Cardiac CT Beyond Traditional Calcium Scoring HOUSTON, TX, UNITED STATES, July 8, 2025 /⁨EINPresswire.com⁩/ -- HeartLung.AI, a leader in AI-powered medical imaging solutions for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 21, 2025 - 22:00 GMT

Capitol Imaging Services Partners with HeartLung to Offer Opportunistic AI Screening for Osteoporosis and Heart Disease

Capitol Imaging Services Partners with HeartLung Technologies to provide AI-powered diagnostics in Cullman and Birmingham, Alabama. HOUSTON, TX, UNITED STATES, May 21, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is thrilled to announce a strategic …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on April 22, 2025 - 18:19 GMT

AI-CVD™ opportunistic detection of fatty liver in coronary calcium scans predicts cardiovascular events and mortality

Research shows HeartLung.AI’s AI-CVD™ improves traditional calcium scores in predicting heart disease risk and all-cause mortality HOUSTON, TX, UNITED STATES, April 22, 2025 /⁨EINPresswire.com⁩/ -- Naghavi M, Atlas K, Reeves A, Zhang C, Wasserthal J, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on April 2, 2025 - 23:03 GMT

HeartLung Technologies Secures CMS Reimbursement for AutoChamber™ with New HCPCS Code

HeartLung proudly announces that CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in CT scans HOUSTON, TX, UNITED STATES, April 2, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 25, 2025 - 21:58 GMT

HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board

HeartLung Technologies proudly announces Dr. Zahi A. Fayad, PhD, joining the advisory board to enhance AI-driven preventive healthcare solutions. HOUSTON, TX, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is proud to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 17, 2025 - 06:23 GMT

HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers

HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamber™) at ACC 2025, offering lifesaving AI solutions for CVD prevention. HOUSTON, TX, UNITED STATES, March 17, 2025 /⁨EINPresswire.com⁩/ -- HeartLung …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 17, 2025 - 06:23 GMT

HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge

HeartLung Technologies selected as a finalist and will compete at the ACC 2025 Innovation Pitch Challenge in Chicago. HOUSTON, TX, UNITED STATES, March 17, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is excited to announce its participation as a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on February 19, 2025 - 12:00 GMT

SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Bone Density Screening Nationwide

Dr. Simon's team at SimonMed Imaging chose HeartLung's AutoBMD™ AI to detect osteoporosis early, marking a significant milestone for both organizations HOUSTON, TX, UNITED STATES, February 19, 2025 /⁨EINPresswire.com⁩/ -- SimonMed Imaging and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 28, 2025 - 16:00 GMT

HeartLung Technologies Welcomes World-Renowned Cardiologist Dr. Robert A. Kloner to the Advisory Board

HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. With over 45 years of experience, he brings unparalleled scientific leadership. HOUSTON, TX, UNITED STATES, January 28, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on November 30, 2024 - 18:47 GMT

HeartLung Technologies to Present Four Cutting-Edge Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at RSNA 2024

HeartLung is the only AI company that is participating in RSNA 2024 both as a scientific presenter of multiple AI research studies and as an industry exhibitor HOUSTON, TX, UNITED STATES, November 30, 2024 /⁨EINPresswire.com⁩/ -- HeartLung Technologies ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on November 18, 2024 - 19:52 GMT

HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the American Heart Association 2024 Conference

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential in primary prevention of cardiovascular disease CHICAGO, TX, UNITED STATES, November 18, 2024 /⁨EINPresswire.com⁩/ -- HeartLung Technologies …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on October 30, 2024 - 17:00 GMT

HeartLung Receives FDA “Breakthrough” Marketing Authorization for First AI to Detect Hidden Heart Disease in CT Scans

New AI flags enlarged heart chambers on non-con CT scans that are invisible to human eye and missed today leading to late-stage heart failure, Afib, and stroke. HOUSTON, TX, UNITED STATES, October 30, 2024 /⁨EINPresswire.com⁩/ -- innovative AI tools for …

Distribution channels: Business & Economy, Companies ...

The Newsroom of HeartLung Corporation